Prostaglandin F2α regulation and function during ovulation and luteinization in cows

• Published in: Theriogenology Vol. 171; pp. 30 - 37
• Main Authors: Pereira de Moraes, Fabiane, Amaral D'Avila, Camila, Caetano de Oliveira, Fernando, Ávila de Castro, Natália, Diniz Vieira, Arnaldo, Schneider, Augusto, Machado Pfeifer, Luiz Francisco, Cantarelli Pegoraro, Lígia Margareth, Ferreira, Rogério, Germano Ferst, Juliana, Tomazele Rovani, Monique, Nunes Correa, Márcio, Dias Gonçalves, Paulo Bayard, Lucia, Thomaz, Garziera Gasperin, Bernardo
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.09.2021
• Subjects: Anti-inflammatory; Cattle; Ovulation; Prostaglandins; Prostaglandins; Cattle; Ovulation; Anti-inflammatory
• ISSN: 0093-691X; 1879-3231
• DOI: 10.1016/j.theriogenology.2021.05.008

Although prostaglandins are important in the ovulation process, a precise role for prostaglandin F2α (PGF) has not been elucidated. This study aimed to evaluate the regulation of PGF receptor mRNA (PTGFR) in granulosa cells and the local effect of PGF on ovulation and luteinization. In Experiment 1, using samples collected in vivo before (Day 2), during (Day 3) and after (Day 4) follicular deviation, expression of PTGFR in bovine granulosa cells was more abundant in the dominant follicle after deviation than in subordinates (P < 0.05). However, the expression of PTGFR was not regulated (P = 0.1) in preovulatory follicles at different time-points (0, 3, 6, 12 and 24 h) after ovulation induction with GnRH. In Experiment 2, to assess the role of systemic PGF treatment on luteinization and vascularization of preovulatory follicles, flunixin meglumine (FM), a nonsteroidal anti-inflammatory drug, was used to inhibit endogenous prostaglandin synthesis. Cows with preovulatory follicles were induced to ovulate with GnRH (0 h) and allocated to three groups: Control, with no further treatment; FM, treated with 2.2 mg/kg FM im 17 h after GnRH treatment; and FM + PGF, treated with FM 17 h after GnRH, followed by 25 mg dinoprost tromethamine (PGF) 23 h after GnRH treatment. FM injection was able to reduce the concentration of PGF in the follicular fluid (FF) (P < 0.001). However, contrary to our hypothesis, color Doppler ultrasound evaluations revealed decreased vascular flow in FM + PGF group (P < 0.05), and no effect of the treatments on intrafollicular P4 and E2 concentrations 24 h after GnRH. The prostaglandin metabolite (PGFM) concentrations in the FF were greater in cows receiving systemic PGF (P < 0.001), which prompted us to further check its role on ovulation. Therefore, in Experiment 3, in a final attempt to demonstrate the local effect of PGF on ovulation, cows with preovulatory follicles received an intrafollicular injection (IFI) of PBS (Control) or 100 ng/mL purified PGF (PGF group). PGF treatment did not affect the time of ovulation after IFI (66 ± 6.4 and 63 ± 8.5 h for control and PGF, respectively; P > 0.05), further suggesting that it has no direct effect in the ovulatory process. Based on our findings, we concluded that FM decreased PGF synthesis within the follicle, whereas PGF treatment decreased follicular vascularization. In addition, the in vivo model of intrafollicular injection evidenced that PGF alone is not able to locally induce ovulation. •Three in vivo studies were conducted to evaluate the regulation and function of PGF during ovulation in cattle.•Granulosa cells of dominant, subordinate and preovulatory follicles expressed PGF receptor (PTGFR).•Systemic flunixin meglumine treatment had an inhibitory effect on the PGF synthesis within the follicle.•Systemic PGF injection decreased follicular vascularization.•Intrafollicular injection of PGF did not hasten ovulation.